Cytokeratin 19 antibody (AA 312-335)
Quick Overview for Cytokeratin 19 antibody (AA 312-335) (ABIN965960)
Target
See all Cytokeratin 19 (KRT19) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 312-335
-
Purification
- Concentrated.
-
Immunogen
- Keratin fraction isolated from Human Breast Cancer MCF-7 cells
-
Isotype
- IgG2a
-
-
-
-
Application Notes
-
Immunohistochemistry: (Paraffin/Frozen): 1:50-1:100
WB: 1:100-1:500.
Staining Procedure: Prolonged fixation in buffered formalin can destroy the epitope. The antibody may be used at a dilution of 1:50 to 1:100 with. The optimal conditions should be determined by the individual laboratory. High temperature antigen unmasking technique predigestion is strongly recommended. -
Comment
-
Cellular Localization: Cytoplasmic.
Recommended Positive Control: Skin, Colonic Carcinoma -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.3 mg/ml
-
Buffer
- 20 mM Tris-Borate, 150 mM Sodium Chloride, dialyzed media RPMI 1640/D-MEM containing Fetal Bovine Serum, BMC-6 Carrier Polysaccharides, Carrier Protein, pH 7.5
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Background
- This antibody reacts with Cytokeratin 19 (40 kD) intermediate filament and with a wide variety of Simple epithelia and non-squamous stratified epithelia. It does not react with stratified squamous epithelia. However, cervical squamous cell carcinomas show positivity with this antibody.
-
Gene ID
- 3880
Target
-